Hydrophilic angiographic catheters market seen reaching $19.13 billion by 2030

The hydrophilic angiographic catheters market is projected to grow from $13.54 billion in 2025 to $19.13 billion by 2030, driven by demand for minimally invasive procedures, coating advances and rising cardiovascular and renal disease cases. Asia-Pacific was the largest regional market in 2025 and remains the fastest-growing region.

Why it matters: - Hydrophilic angiographic catheters are used in cardiovascular and interventional radiology procedures where smoother navigation can improve procedure control and support better outcomes. - Market growth signals more demand for minimally invasive treatment tools as healthcare systems expand cardiac, renal and imaging capacity. - Rising renal and cardiovascular disease prevalence is increasing the need for diagnostic and interventional procedures that rely on these catheters.

What happened: - The Business Research Company published an outlook on the hydrophilic angiographic catheters market on August 11, 2026. - The market is estimated at $13.54 billion in 2025 and is forecast to reach $14.55 billion in 2026. - The report projects the market will climb to $19.13 billion by 2030. - The 2025 to 2026 growth rate is 7.4%, and the 2026 to 2030 forecast CAGR is 7.1%. - Asia-Pacific was the largest regional market in 2025 and is also described as the fastest-growing market globally.

The details: - Hydrophilic angiographic catheters use a coating that lowers friction and helps the catheter move more easily through blood vessels. - The devices are used in both diagnostic and therapeutic procedures tied to cardiovascular disease. - Growth in the market has been fueled by higher cardiovascular disease incidence, more angiographic procedures, reliance on traditional catheters, more hospital-based interventional treatments and advances in catheter materials. - Future demand is expected to come from wider use of minimally invasive treatments, hydrophilic coating innovation, expansion in interventional cardiology and radiology, higher spending on cardiac care and broader access to advanced imaging and catheterization facilities. - The report highlights several trends, including greater use of hydrophilic coatings to reduce friction, wider adoption in minimally invasive cardiovascular procedures, stronger demand for selective angiographic catheters, improved trackability in complex vessels and more focus on procedural safety and physician precision. - Rising renal disorders are a key growth driver because the catheters support smooth, precise navigation in renal artery angiography and stenting. - Kidney Research UK reported in June 2023 that about 7.2 million people in the UK live with chronic kidney disease, or more than 10% of the population. - Of those UK patients, 3.25 million are in advanced stages and about 3.9 million are in earlier stages. - Kidney Research UK projected that the UK chronic kidney disease population will rise to 7.61 million by 2033. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, plus updated graphics and tables. - The report offers a free sample and a full version through the company’s sample page and the full report.

Between the lines: - The forecast points to a steady, not explosive, expansion profile, suggesting a mature medical-device category with demand tied to procedure volumes and disease burden. - Asia-Pacific’s lead reflects both rising healthcare investment and faster adoption of advanced medical technologies across the region. - The emphasis on friction reduction, trackability and safety indicates competition is shifting toward performance features that help physicians work in tighter and more complex vessels.

What's next: - The market is expected to keep expanding through 2030 as interventional cardiology and radiology continue to adopt more advanced catheter designs. - Growth in renal care, imaging infrastructure and minimally invasive procedures should remain the main demand signals to watch. - The Business Research Company is directing readers to its report materials and expert contacts for additional market detail.

The bottom line: - Hydrophilic angiographic catheters are moving from a niche procedural tool to a steady growth market, with disease burden, coating innovation and minimally invasive care shaping the outlook.